Fetal microchimerism cells suppress arthritis progression by inducing CD14+ IL‐10+ cells in pregnant experimental mice
International Journal of Rheumatic Diseases · 2024
DOI: 10.1111/1756-185x.15322 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Da-Wei Chang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC. Hauptthemen laut MEDLINE: Interleukin-10, Mice, Inbred C57BL, Disease Progression, Lipopolysaccharide Receptors. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Taipei Veterans General Hospital.
Abstract (Originalsprache)
Background
Fetal microchimerism occurs in the mother after a pregnancy. To investigate the role of fetal microchimerism cells (FMCs) in rheumatoid arthritis, we analyzed the population of fetal cells in pregnant experimental arthritis mice.
Methods
We used EGFP+ fetuses, which were mated with either healthy female mice or CIA mice, and male C57BL/6J‐Tg (Pgk1‐EGFP)03Narl mice, to detect the population of FMCs in maternal circulation. The disease progression was determined by measuring the clinical score and histological stains during pregnancy. The fetal cells have been analyzed if expressing EGFP, CD45, and Scal by flow cytometry. We also detected the expression of CD14+ IL‐10+ cells in vivo and in vitro.
Results
Our data showed that the pregnancy ameliorated the arthritis progression of CIA mice. The IHC stains showed the CD45 − Sca‐1 + EGFP + FMCs were expressed in the bone marrow and peripheral blood mononuclear cells (PBMC) at 14 gestation days. However, Treg and Tc cell populations showed no significant change in the bone marrow. The data showed the H2Kb + fetal cells induced CD14 + IL10 + cell populations increased in the bone marrow in vitro and in vivo.
Conclusion
Our investigations demonstrated that the FMCs protected the CIA mice from cartilage damage and triggered an immunosuppressive response in them by increasing the number of CD14 + IL10 + cells. In conclusion, the FMCs could potentially exhibit protective properties within the context of inflammatory arthritis that arises during pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
- Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan, ROC.
- Division of Allergy/Immunology/Rheumatology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.
- Division of Allergy/Immunology/Rheumatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
ORCID-Profile: Da-Wei Chang, Chun-Chi Lu, Chen-Chih Chu, Deh-Ming Chang
Förderung
- Taipei Veterans General Hospital
Zitieren
APA
Chang, D. W., Wu, C. C., Liu, F. L., Lu, C. C., Chu, C. C., & Chang, D. M. (2024). Fetal microchimerism cells suppress arthritis progression by inducing CD14+ IL‐10+ cells in pregnant experimental mice. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15322
Vancouver
Chang DW, Wu CC, Liu FL, Lu CC, Chu CC, Chang DM. Fetal microchimerism cells suppress arthritis progression by inducing CD14+ IL‐10+ cells in pregnant experimental mice. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15322
BibTeX
@article{Chang2024,
author = {Chang, Da-Wei and Wu, Cheng-Chi and Liu, Fei-Lan and Lu, Chun-Chi and Chu, Chen-Chih and Chang, Deh-Ming},
title = {Fetal microchimerism cells suppress arthritis progression by inducing CD14+ IL‐10+ cells in pregnant experimental mice},
journal = {International Journal of Rheumatic Diseases},
year = {2024},
doi = {10.1111/1756-185x.15322}
}
EUVIMED